David H. Peyton

Corporate Officer/Principal bei Portland State University

Consumer Services

Health Technology

Aktive Positionen von David H. Peyton

Unternehmen	Position	Beginn	Ende
Portland State University	Corporate Officer/Principal	30.10.2009	-

Unternehmen	Position	Beginn	Ende
DesignMedix, Inc. DesignMedix, Inc. Pharmaceuticals: MajorHealth Technology DesignMedix, Inc. develops drugs to overcome drug-resistant diseases. Its pipeline includes RCQ anti-malaria drugs, modified acridone and anti-bacterial drugs. The firm is a drug development company, which develops drugs to overcome drug resistance with a focus on curing malaria in Oregon. It develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. The company was founded by Sandra Lee Shotwell, David H. Peyton and Lynnor B. Stevenson in 2006 and is headquartered in Portland, OR.	Direktor/Vorstandsmitglied	-	-
	Technik-/Wissenschafts-/F&E-Leiter	-	-
	Gründer	01.01.2006	-

Abilene Christian University	Undergraduate Degree
University of California, Santa Barbara	Doctorate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Consumer Services	4
Health Technology	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
DesignMedix, Inc. DesignMedix, Inc. Pharmaceuticals: MajorHealth Technology DesignMedix, Inc. develops drugs to overcome drug-resistant diseases. Its pipeline includes RCQ anti-malaria drugs, modified acridone and anti-bacterial drugs. The firm is a drug development company, which develops drugs to overcome drug resistance with a focus on curing malaria in Oregon. It develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. The company was founded by Sandra Lee Shotwell, David H. Peyton and Lynnor B. Stevenson in 2006 and is headquartered in Portland, OR.	Health Technology

Private Unternehmen

Health Technology